(NASDAQ: CBUS) Cibus's forecast annual revenue growth rate of 148.05% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 106.08%, and it is also forecast to beat the US market's average forecast revenue growth rate of 24.88%.
Cibus's revenue in 2025 is $4,846,000.On average, 7 Wall Street analysts forecast CBUS's revenue for 2025 to be $272,005,486, with the lowest CBUS revenue forecast at $227,258,821, and the highest CBUS revenue forecast at $341,701,807. On average, 7 Wall Street analysts forecast CBUS's revenue for 2026 to be $444,537,779, with the lowest CBUS revenue forecast at $333,891,480, and the highest CBUS revenue forecast at $569,503,011.
In 2027, CBUS is forecast to generate $4,962,106,854 in revenue, with the lowest revenue forecast at $2,571,875,598 and the highest revenue forecast at $7,460,489,444.